Hoxton Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Hoxton Financial’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$7K	Hold	172	–	–	﹤0.01%	272
2015 Q4	$9K	Sell	172 -162,361	-100%	-$8.27M	﹤0.01%	241
2015 Q3	$7.63M	Buy	162,533 +171	+0.1%	+$10.3K	3.62%	15
2015 Q2	$10.1M	Sell	162,362 -1,390	-0.8%	-$86.6K	4.2%	11
2015 Q1	$10.1M	Sell	163,752 -9,730	-6%	-$577K	4.29%	11
2014 Q4	$9.37M	Sell	173,482 -9,096	-5%	-$497K	3.91%	11
2014 Q3	$9.68M	Sell	182,578 -2,710	-1%	-$138K	4.24%	11
2014 Q2	$9.62M	Sell	185,288 -6,090	-3%	-$294K	4.11%	11
2014 Q1	$8.96M	Sell	191,378 -15,536	-8%	-$734K	3.79%	12
2013 Q4	$9.1M	Buy	+206,914	New	+$8.62M	3.92%	12
2013 Q3	–	Sell	-220,978	Closed	-$7.79M	–	622
2013 Q2	$7.79M	Buy	+220,978	New	+$7.46M	4.4%	10

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Hoxton Financial's XPH Position: Q1 2016 in Review

Hoxton Financial held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q1 2016 at 172 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Hoxton Financial first reported a position in XPH in Q2 2013 and has held it in 11 quarters since. The position peaked at $10.1M in Q2 2015. 71 funds tracked by Wall St. Rank hold XPH as of Q1 2016.

Hoxton Financial held 172 shares of State Street SPDR S&P Pharmaceuticals ETF worth $7K as of Q1 2016.
Hoxton Financial left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q1 2016.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Hoxton Financial's portfolio in Q1 2016, its #272 holding.
Hoxton Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 11 quarters since.
Hoxton Financial's State Street SPDR S&P Pharmaceuticals ETF position peaked at $10.1M in Q2 2015.
71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.